Biogenetics company Klotho Neurosciences has announced plans to acquire assets from Turn Biotechnologies, marking a move in ...
Patients gain access to AI-powered analysis, DNA-based protocols, and non-invasive treatments with 90%+ success rates Jacqueline Joy Battjes' commitment to functional and regenerative medicine aligns ...
The scientific community rarely witnesses paradigm shifts that redefine entire fields of medicine. Marc Malone’s years of deep research leading to Airmid Biogenetics represent a moment where urgent ...
An update from Klotho Neurosciences ( (KLTO)) is now available. On June 30, 2025, Klotho Neurosciences announced the commencement of manufacturing for its gene therapy candidate KLTO-202, aimed at ...
Shares of the anti-aging biogenetics company Klotho Neurosciences, Inc. (NASDAQ:KLTO) are on retail investors' radars after the stock exploded by more than 500% in June. Here's a look at recent ...
NEW YORK, June 30, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO) today announced that it is moving forward with manufacturing and process development work in preparation for clinical ...
NEW YORK, June 16, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO), a U.S.-based biogenetics company, today announced that over the course of the last ten days, it raised over $11 ...
Shares of Klotho Neurosciences Inc (NASDAQ:KLTO) skyrocketed over 680% to $1.60 during Monday morning trading after the company highlighted promising pre-clinical study findings for its anti-aging ...
Zacks.com on MSN
Is it Wise to Retain Rayonier Stock in Your Portfolio Now?
Rayonier Inc. RYN enjoys a solid timberland portfolio in some of the most productive timber-growing regions of the U.S. South, the Pacific Northwest and New Zealand. The company is poised to benefit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback